Verastem to Present at 2015 UBS Global Health Care Conference

BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the 2015 UBS Global Healthcare Conference on Tuesday, May 19 at 1:30 p.m. ET at the Sheraton New York Times Square Hotel in New York City.

A live webcast of the presentation will be available on the company's website at http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-calendar. An archived presentation will be available for 90 days.

About Verastem, Inc.

Verastem, Inc. (NASDAQ: VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK and PI3K/mTOR. For more information, please visit www.verastem.com.

Verastem, Inc.
Brian Sullivan, 781-292-4214
[email protected]

Source: Verastem, Inc.

You May Also Be Interested In

• Mizuho Reiterates Outperform Rating on Verastem (VSTM), maintain "June top pick"
• Gores Holdings XI, Inc. Announces Pricing of $312 Million Initial Public Offering
• Shenzhen HQVT Technology Lists on HKEX Main Board, Accelerating Implementation of Multispectral AI Technology